Home › Funds › Two Sigma Investments › RNAZ
Two Sigma Investments position in RNAZ
TransCode Therapeutics Inc · Health Care
Latest position (Q3 2023)16.15K sh
Reported value held$8.12K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 76.64K | $229.00K | New |
| Q4 2022 | 19.41K | $13.06K | New |
| Q1 2023 | 19.41K | $6.57K | Hold |
| Q3 2023 | 16.15K | $8.12K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RNAZ
- UBS Group AG 2.89K sh · $17.93K · Q2 2026
- MERCER GLOBAL ADVISORS INC /ADV 1.53K sh · $9.53K · Q2 2026
- Fidelity Management & Research (FMR) 706 sh · $4.38K · Q2 2026
- Wells Fargo & Co 55 sh · $342 · Q2 2026
- SBI Securities Co., Ltd. 12 sh · $75 · Q2 2026